Stock A005250 GREEN CROSS HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Green Cross Holdings Corporation

Equities

A005250

KR7005250006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
15,510 KRW -0.77% Intraday chart for Green Cross Holdings Corporation +1.97% -5.14%
Mar. 20 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Tiantan Biological Unit Registers Blood Disorder Treatment; Shares Jump 4% MT

Business Summary

Green Cross Holdings Corp is a Korea-based investment holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The Company is also involved in the real estate sales and leasing, as well as construction business.

Number of employees: 165

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals
73.3 %
1,530,200 73.6 % 1,507,856 73.3 % -1.46%
Others
11.2 %
208,975 10.0 % 231,406 11.2 % +10.73%
Diagnosis and Analysis of Specimens, Etc.
10.7 %
264,374 12.7 % 220,290 10.7 % -16.67%
Development and Supply of Medical Services and Systems
9.3 %
166,042 8.0 % 191,663 9.3 % +15.43%
Consolidated Adjustment
-7.4 %
-156,801 -7.5 % -152,986 -7.4 % -2.43%
Leasing and Service
2.9 %
66,770 3.2 % 59,707 2.9 % -10.58%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
89.7 %
1,867,074 89.8 % 1,845,445 89.7 % -1.16%
Overseas
17.8 %
369,287 17.8 % 365,476 17.8 % -1.03%
Consolidated Adjustment
-7.4 %
-156,801 -7.5 % -152,985 -7.4 % -2.43%

Managers

Managers TitleAgeSince
Yong-Jun Huh CEO
 Chief Executive Officer 49 10-02-28
Il-Sup Huh CEO
 Chief Executive Officer 69 91-05-31
Yeon-Geun Kim DFI
 Director of Finance/CFO 51 -
Won-Gyu Seo CMP
 Compliance Officer 55 -
Je-Tae Moon AUD
 Comptroller/Controller/Auditor 67 15-02-28

Members of the board

Members of the board TitleAgeSince
Il-Sup Huh CEO
 Chief Executive Officer 69 91-05-31
Yong-Tae Park BRD
 Director/Board Member 74 09-02-28
Yong-Jun Huh CEO
 Chief Executive Officer 49 10-02-28
Seok-Hwa Kim BRD
 Director/Board Member 69 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 845,990 240,657 ( 28.45 %) 605,333 ( 71.55 %) 44.02 %
Stock B 0 1,668,870 0 1,441,986 ( 86.40 %)
Stock C 1 47,028,210 21,566,058 ( 45.86 %) 2,094,020 ( 4.453 %)

Shareholders

NameEquities%Valuation
Il-Sup Huh
12.20 %
5,737,777 12.20 % 73 M ₩
MOGAM Institute
8.723 %
4,102,190 8.723 % 52 M ₩
National Pension Service of Korea
6.928 %
3,258,009 6.928 % 42 M ₩
Yong-Tae Park
4.942 %
2,324,000 4.942 % 30 M ₩
GREEN CROSS HOLDINGS CORPORATION
4.453 %
2,094,020 4.453 % 27 M ₩
Mirae Nanum Foundation
4.379 %
2,059,600 4.379 % 26 M ₩
Jung-mi Huh
3.252 %
1,529,403 3.252 % 20 M ₩
Yong-Jun Huh
2.908 %
1,367,454 2.908 % 17 M ₩
Eun-Cheol Huh
2.631 %
1,237,522 2.631 % 16 M ₩
Mok Am Science Scholarship Foundation
2.098 %
986,480 2.098 % 13 M ₩
NameEquities%Valuation
GREEN CROSS HOLDINGS CORPORATION
81.41 %
2,047,319 81.41 % 44 M ₩
DWS Investment SA Luxembourg (Investment Management)
2.007 %
50,479 2.007 % 1 M ₩

Holdings

NameEquities%Valuation
GC BIOPHARMA CORP.
50.06%
 5,850,482 50.06% 527,140,948 $
UBCARE. CO., LTD.
52.65%
 27,482,155 52.65% 104,722,950 $
GC CELL CORPORATION
8.48%
 1,339,318 8.48% 41,783,735 $
GREEN CROSS HOLDINGS CORPORATION
4.45%
 2,094,020 4.45% 26,738,123 $
GREEN CROSS WELLBEING CORPORATION
12.39%
 2,198,700 12.39% 16,838,326 $
VUNO INC.
2.19%
 300,000 2.19% 7,052,925 $
CARELABS CO.,LTD
0.21%
 40,000 0.21% 135,488 $

Company contact information

Green Cross Holdings Corp.

107 Ihyeon-ro 30beon-gil Giheung-gu

16924, Yongin-si

+

http://www.greencross.com
address Green Cross Holdings Corporation(A005250)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
GREEN CROSS HOLDINGS CORPORATION Stock Green Cross Holdings Corporation
-5.14% 514M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.66% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.15% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.65% 196B
NOVARTIS AG Stock Novartis AG
+6.86% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A005250 Stock
  4. Company Green Cross Holdings Corporation